211 related articles for article (PubMed ID: 31808900)
1. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C; Pagliuca S; Prata PH; Galimard JE; Catto LFB; Larcher L; Sebert M; Allain V; Patel BJ; Durmaz A; Pinto AL; Inacio MCB; Hernandez L; Dhedin N; Caillat-Zucman S; Clappier E; Sicre de Fontbrune F; Voso MT; Visconte V; Peffault de Latour R; Soulier J; Calado RT; Socié G; Maciejewski JP
J Clin Oncol; 2023 Jan; 41(1):132-142. PubMed ID: 36054881
[TBL] [Abstract][Full Text] [Related]
3. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
Schaefer EJ; Lindsley RC
Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
[TBL] [Abstract][Full Text] [Related]
4. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
6. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
Visconte V; Lindsley RC; Berlyne D
Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
Stanley N; Olson TS; Babushok DV
Br J Haematol; 2017 May; 177(4):509-525. PubMed ID: 28107566
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.
Liu L; Zhang D; Fu Q; Wang J; Yu J; Chen D; Wang F; Guo R; Xie X; Jiang Z; Li Y
Clin Exp Med; 2023 Dec; 23(8):4473-4482. PubMed ID: 37087521
[TBL] [Abstract][Full Text] [Related]
9. [Immune pathophysiology of bone marrow failure].
Hosokawa K
Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
Frietsch JJ; Dornaus S; Neumann T; Scholl S; Schmidt V; Kunert C; Sayer HG; Hochhaus A; La Rosée P
Eur J Haematol; 2014 Sep; 93(3):247-59. PubMed ID: 24635656
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.
Maciejewski JP; Balasubramanian SK
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):66-72. PubMed ID: 29222238
[TBL] [Abstract][Full Text] [Related]
12. [Sternal bone marrow cell morphology evaluation utility for diagnostic categorization in patients with acquired hypocellular bone marrow failure syndromes].
Chen J; Qin TJ; Qu SQ; Pan LJ; Zhang PH; Li B; Xiao ZJ; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2022 Nov; 43(11):928-933. PubMed ID: 36709184
[No Abstract] [Full Text] [Related]
13. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.
Barcellini W
Expert Rev Hematol; 2017 Jul; 10(7):649-657. PubMed ID: 28586251
[TBL] [Abstract][Full Text] [Related]
14. Clonality in context: hematopoietic clones in their marrow environment.
Cooper JN; Young NS
Blood; 2017 Nov; 130(22):2363-2372. PubMed ID: 29046282
[TBL] [Abstract][Full Text] [Related]
15. [Clonal evolution and clinical significance of trisomy 8 in acquired bone marrow failure].
Zhou LW; Shi J; Huang ZD; Nie N; Shao YQ; Li XX; Ge ML; Zhang J; Jin P; Huang JB; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):507-511. PubMed ID: 31340625
[No Abstract] [Full Text] [Related]
16. Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?
Gurnari C; Pagliuca S; Maciejewski JP
Leuk Lymphoma; 2023; 64(8):1389-1399. PubMed ID: 37356012
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
Bejar R
Curr Hematol Malig Rep; 2015 Sep; 10(3):282-91. PubMed ID: 26126599
[TBL] [Abstract][Full Text] [Related]
18. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
Zhao XC; Ju B; Xiu NN; Sun XY; Meng FJ
Front Immunol; 2024; 15():1339971. PubMed ID: 38426096
[TBL] [Abstract][Full Text] [Related]
19. Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology.
Tohyama K
Int J Lab Hematol; 2018 May; 40 Suppl 1():120-125. PubMed ID: 29741254
[TBL] [Abstract][Full Text] [Related]
20. The stem cell fitness landscape and pathways of molecular leukemogenesis.
Bagby GC; Fleischman AG
Front Biosci (Schol Ed); 2011 Jan; 3(2):487-500. PubMed ID: 21196392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
